This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2025 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Mindy Jones
Executive Director, Rare Disease Strategic Solutions at Biogen
Speaker

Profile

Mindy Jones is the Rare Disease Strategic Solutions Lead at Biogen, where she applies her extensive operational expertise to deliver solutions that address critical treatment journey and business priorities. With over 20 years of experience, she has designed and managed innovative manufacturer programs that enhance patient experience, acquisition, access, and retention across Rare Disease and Immunology. Mindy has successfully led national U.S. Patient Support Program (PSP) operational teams, managed Risk Evaluation and Mitigation Strategy (REMS) hubs, and built a robust compliance infrastructure to support these programs, ensuring adaptability to the ever-evolving healthcare landscape.

Mindy holds a Master of Healthcare Administration from the University of North Carolina at Chapel Hill, as well as undergraduate degrees in management and social sciences from the same institution. Her academic background, combined with her commitment to continuous professional development, strong affinity for data-driven insights, and appreciation for pharmacy and distributor partnerships, informs her strategic leadership in rare disease services and operational excellence.

Agenda Sessions

  • Revolutionizing Rare Disease Care: Patient-Centric Engagement Through Interdisciplinary Collaboration, Specialty Pharmacies and Technology

    3:45pm